The overall goals of the Molecular Oncology research program are to understand the fundamental cellular and molecular processes that contribute to cancer development and progression.
Normal cells have intricate molecular mechanisms that control essential phenotypes such as differentiation, cell division and movement. The molecular pathways that control these phenotypes are disrupted in cancer cells as a result of the expression of oncogenes and loss of regulatory tumor suppressor genes. These events, which are often highly specific to individual types of cancer, disrupt specific molecular pathways that result in uncontrolled cell growth and loss of normal responses to extracellular signaling cues that result in tumor development and progression.
The research interests of the program can be divided into three broad themes:
The grant awarded for Chadli’s research focuses on a specific protein, UNC45A, that can be used as a promising novel immunotherapeutic target in treating triple-negative breast cancer (TNBC).
This summer, high school students participated in the Georgia Cancer Center's first Summer Research Experience Program.
It is a key to life, but not every person living in Augusta has the same access to healthy food as their neighbors across the region.
A study conducted by a team of researchers from the Dental College of Georgia at Augusta University tested inhalant CBD in the treatment of lung cancer and whether it could inhibit tumors from growing or spreading.
